tiprankstipranks
Advertisement
Advertisement

ABCL Stock Latest News

AbCellera Biologics call volume above normal and directionally bullish
The FlyAbCellera Biologics call volume above normal and directionally bullish
4d ago
ABCL
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
5d ago
YSS
ABCL
AbCellera 17.4M share Secondary priced at $9.75
PremiumThe Fly
AbCellera 17.4M share Secondary priced at $9.75
7d ago
ABCL
AbCellera Biologics call volume above normal and directionally bullish
PremiumThe Fly
AbCellera Biologics call volume above normal and directionally bullish
7d ago
ABCL
AbCellera Biologics Announces Oversubscribed $200 Million Offering
PremiumCompany Announcements
AbCellera Biologics Announces Oversubscribed $200 Million Offering
10d ago
8K
ABCL
AbCellera announces $200M common stock, warrants offering
PremiumThe FlyAbCellera announces $200M common stock, warrants offering
12d ago
ABCL
AbCellera price target raised to $30 from $12 at Truist
Premium
The Fly
AbCellera price target raised to $30 from $12 at Truist
12d ago
ABCL
AbCellera Price Target Raised to $15 on Best-in-Class ABCL635 Phase 2 Data and Strategic Pipeline Momentum
Premium
Ratings
AbCellera Price Target Raised to $15 on Best-in-Class ABCL635 Phase 2 Data and Strategic Pipeline Momentum
12d ago
ABCL
AbCellera price target raised to $25 from $13 at JonesResearch
PremiumThe Fly
AbCellera price target raised to $25 from $13 at JonesResearch
13d ago
ABCL
AbCellera announces Phase 1/2 trial of ABCL635 met primary efficacy endpoints
PremiumThe Fly
AbCellera announces Phase 1/2 trial of ABCL635 met primary efficacy endpoints
14d ago
ABCL
AbCellera Earnings Call Balances Cash Strength With Risk
PremiumCompany Announcements
AbCellera Earnings Call Balances Cash Strength With Risk
15d ago
ABCL
AbCellera to Report Phase 2 Menopause Therapy Data
PremiumCompany Announcements
AbCellera to Report Phase 2 Menopause Therapy Data
16d ago
8K
ABCL
AbCellera price target raised to $9 from $8 at Stifel
PremiumThe FlyAbCellera price target raised to $9 from $8 at Stifel
17d ago
ABCL
AbCellera price target raised to $12 from $11 at Cantor Fitzgerald
Premium
The Fly
AbCellera price target raised to $12 from $11 at Cantor Fitzgerald
17d ago
ABCL
Analyst Brendan Smith Reiterates Buy on AbCellera, Citing Strong Liquidity and Upcoming Phase 2 Data for ABCL635 in Hot-Flash Market
Premium
Ratings
Analyst Brendan Smith Reiterates Buy on AbCellera, Citing Strong Liquidity and Upcoming Phase 2 Data for ABCL635 in Hot-Flash Market
18d ago
ABCL
AbCellera reports Q2 EPS (18c), consensus (17c)
PremiumThe Fly
AbCellera reports Q2 EPS (18c), consensus (17c)
18d ago
ABCL
AbCellera and Vertex launch autoimmune T-cell engager partnership
PremiumCompany Announcements
AbCellera and Vertex launch autoimmune T-cell engager partnership
25d ago
8K
ABCL
AbCellera announces collaboration with Vertex Pharmaceuticals
PremiumThe Fly
AbCellera announces collaboration with Vertex Pharmaceuticals
26d ago
ABCL
VRTX
3 Under-$10 Stocks with Strong Upside to Watch This Week, According to Analysts
PremiumMarket News
3 Under-$10 Stocks with Strong Upside to Watch This Week, According to Analysts
2M ago
ABCL
NUVB
AbCellera Biologics call volume above normal and directionally bullish
PremiumThe FlyAbCellera Biologics call volume above normal and directionally bullish
2M ago
ABCL
AbCellera upgraded to Buy from Hold at Benchmark
Premium
The Fly
AbCellera upgraded to Buy from Hold at Benchmark
2M ago
ABCL
JAZZ
AbCellera Biologics Adds Independent Director to Board
Premium
Company Announcements
AbCellera Biologics Adds Independent Director to Board
2M ago
8K
ABCL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >